BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Patanè S. Prostate-specific antigen kallikrein and the heart. World J Cardiol 2009; 1(1): 23-25 [PMID: 21160572 DOI: 10.4330/wjc.v1.i1.23]
URL: https://www.wjgnet.com/1949-8462/full/v1/i1/23.htm
Number Citing Articles
1
Salvatore Patanè. Regulator of G-protein signaling 6 (RGS6) in cardiology and oncologyInternational Journal of Cardiology 2015; 187 doi: 10.1016/j.ijcard.2015.03.278
2
M. Scarano, F. Pezzuoli, G. Torrisi, G.M. Calvagna, S. Patanè. Cardiovascular implantable electronic device infective endocarditisInternational Journal of Cardiology 2014; 173(3) doi: 10.1016/j.ijcard.2014.03.075
3
Antonio Maria Labate, Provvidenza Villari, Roberto La Rocca, Andrea Gervasio, Salvatore Patanè. Acute pulmonary embolism (PE) as the most serious clinical presentation of venous thromboembolism (VTE)International Journal of Cardiology 2015; 195 doi: 10.1016/j.ijcard.2015.05.119
4
Salvatore Patanè. Cancer multidrug resistance-targeted therapy in both cancer and cardiovascular system with cardiovascular drugsInternational Journal of Cardiology 2014; 176(3) doi: 10.1016/j.ijcard.2014.07.158
5
Pietro Pugliatti, Concetta Zito, Rosaria Adamo, Salvatore Calcaterra, Salvatore Patanè. Mitral valve prolapse caused from ruptured mitral chordae tendineae due to an infective endocarditis in cancer patientInternational Journal of Cardiology 2015; 195 doi: 10.1016/j.ijcard.2015.05.113
6
Salvatore Patanè. Prostate-specific antigen kallikrein, non-ST elevation myocardial infarction and a new-onset atrial fibrillation in hypertensive patientsInternational Journal of Cardiology 2013; 167(1) doi: 10.1016/j.ijcard.2012.09.208
7
Placido Romeo, Giuseppe Mario Calvagna, Marco Giunta, Felice Vito Vitale, Salvatore Patanè. Removal of an intracardiac lost port-A catheter utilizing a simple low-cost methodInternational Journal of Cardiology 2014; 176(3) doi: 10.1016/j.ijcard.2014.07.156
8
Salvatore Patanè. Cardiotoxicity: Cisplatin and long-term cancer survivorsInternational Journal of Cardiology 2014; 175(1) doi: 10.1016/j.ijcard.2014.04.238
9
Salvatore Patanè. Cardiotoxicity: Trastuzumab and cancer survivorsInternational Journal of Cardiology 2014; 177(2) doi: 10.1016/j.ijcard.2014.08.117
10
Salvatore Patanè. ERBB1/EGFR and ERBB2 (HER2/neu) — Targeted therapies in cancer and cardiovascular system with cardiovascular drugsInternational Journal of Cardiology 2014; 176(3) doi: 10.1016/j.ijcard.2014.07.161
11
Pietro Pugliatti, Antonino Recupero, Concetta Zito, Salvatore Patanè. The chance finding of an atrial septal defect in a cancer patientInternational Journal of Cardiology 2014; 177(2) doi: 10.1016/j.ijcard.2014.09.153
12
Salvatore Patanè. Insights into cardio-oncology: The patient's heavy cancer journey among doubts, controversies and pitfalls. The role of the cardiologistInternational Journal of Cardiology 2015; 178 doi: 10.1016/j.ijcard.2014.10.167
13
Salvatore Patanè. Prostate-specific antigen kallikrein and non-ST elevation myocardial infarctionInternational Journal of Cardiology 2011; 149(3) doi: 10.1016/j.ijcard.2011.03.015
14
Meera Srivastava, Ofer Eidelman, James Craig, Joshua Starr, Leonid Kvecher, Jianfang Liu, Matthew Hueman, Harvey B Pollard, Hai Hu, Craig D Shriver. Serum Biomarkers for Racial Disparities in Breast Cancer ProgressionMilitary Medicine 2019; 184(Supplement_1) doi: 10.1093/milmed/usy417
15
Salvatore Patanè. Cardiotoxicity: Anthracyclines and long term cancer survivorsInternational Journal of Cardiology 2014; 176(3) doi: 10.1016/j.ijcard.2014.07.149
16
Pietro Pugliatti, Rocco Donato, Cesare de Gregorio, Salvatore Patanè. A massive pericardial effusion in a cancer patientInternational Journal of Cardiology 2015; 181 doi: 10.1016/j.ijcard.2014.11.141
17
Salvatore Patanè. HERG-targeted therapy in both cancer and cardiovascular system with cardiovascular drugsInternational Journal of Cardiology 2014; 176(3) doi: 10.1016/j.ijcard.2014.07.129
18
Esther Fernández-Galán, Josep M. Augé, Rafael Molina, Xavier Filella. Very high levels of PSA in patients with cardiogenic shock: Report of four clinical casesClinical Biochemistry 2020; 76 doi: 10.1016/j.clinbiochem.2019.11.002
19
Salvatore Patanè. M3 muscarinic acetylcholine receptor in cardiology and oncologyInternational Journal of Cardiology 2014; 177(2) doi: 10.1016/j.ijcard.2014.09.178
20
Salvatore Patanè. Regulator of G-protein signaling 2 (RGS2) in cardiology and oncologyInternational Journal of Cardiology 2015; 179 doi: 10.1016/j.ijcard.2014.10.088
21
Salvatore Patanè, Filippo Marte. Prostate-specific antigen levels in hypertensive patients suffering from a non-ST elevation myocardial infarction or a new-onset atrial fibrillationInternational Journal of Cardiology 2012; 158(3) doi: 10.1016/j.ijcard.2011.01.066